Innovations in First Line Therapy for DLBCL - 7 February 2024
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only! Grab it Explore cutting-edge advancements in first-line therapy for Diffuse Large B-Cell Lymphoma (DLBCL) in this informative Grand Rounds presentation. Led by Dr. Christopher Flowers, Head of the Division of Cancer Medicine and Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, the 54-minute talk delves into the latest research and treatment strategies. Gain valuable insights into innovative approaches that are shaping the future of DLBCL management and improving patient outcomes. This presentation, hosted by the Stanford Department of Medicine, offers a unique opportunity to stay abreast of the evolving landscape in lymphoma treatment.